447 related articles for article (PubMed ID: 23775448)
1. Sonographic discrimination between benign and malignant adnexal masses in premenopause.
Radosa MP; Vorwergk J; Fitzgerald J; Kaehler C; Schneider U; Camara O; Runnebaum IB; Schleußner E
Ultraschall Med; 2014 Aug; 35(4):339-44. PubMed ID: 23775448
[TBL] [Abstract][Full Text] [Related]
2. Preoperative multimodal strategies for risk assessment of adnexal masses: analysis of 1362 cases in a gynecologic cancer center.
Radosa MP; Camara O; Vorwergk J; Diebolder H; Winzer H; Mothes A; Gajda M; Runnebaum IB
Int J Gynecol Cancer; 2011 Aug; 21(6):1056-62. PubMed ID: 21633301
[TBL] [Abstract][Full Text] [Related]
3. Discrimination between benign and malignant adnexal masses by specialist ultrasound examination versus serum CA-125.
Van Calster B; Timmerman D; Bourne T; Testa AC; Van Holsbeke C; Domali E; Jurkovic D; Neven P; Van Huffel S; Valentin L
J Natl Cancer Inst; 2007 Nov; 99(22):1706-14. PubMed ID: 18000221
[TBL] [Abstract][Full Text] [Related]
4. The risk of malignancy index in discrimination of adnexal masses.
Ulusoy S; Akbayir O; Numanoglu C; Ulusoy N; Odabas E; Gulkilik A
Int J Gynaecol Obstet; 2007 Mar; 96(3):186-91. PubMed ID: 17280665
[TBL] [Abstract][Full Text] [Related]
5. External validation of the adapted Risk of Malignancy Index incorporating tumor size in the preoperative evaluation of adnexal masses.
van den Akker PA; Zusterzeel PL; Aalders AL; Snijders MP; Samlal RA; Vollebergh JH; Kluivers KB; Massuger LF
Eur J Obstet Gynecol Reprod Biol; 2011 Dec; 159(2):422-5. PubMed ID: 21824712
[TBL] [Abstract][Full Text] [Related]
6. The accuracy of risk malignancy index in prediction of malignancy in women with adnexal mass in Basrah, Iraq.
Al-Asadi JN; Al-Maliki SK; Al-Dahhhan F; Al-Naama L; Suood F
Niger J Clin Pract; 2018 Oct; 21(10):1254-1259. PubMed ID: 30297555
[TBL] [Abstract][Full Text] [Related]
7. Differential diagnosis of adnexal masses: sequential use of the risk of malignancy index and HistoScanning, a novel computer-aided diagnostic tool.
Vaes E; Manchanda R; Autier P; Nir R; Nir D; Bleiberg H; Robert A; Menon U
Ultrasound Obstet Gynecol; 2012 Jan; 39(1):91-8. PubMed ID: 21695741
[TBL] [Abstract][Full Text] [Related]
8. Transvaginal color Doppler ultrasonography and CA-125 in suspicious adnexal masses.
Alcázar JL; Errasti T; Zornoza A; Mínguez JA; Galán MJ
Int J Gynaecol Obstet; 1999 Sep; 66(3):255-61. PubMed ID: 10580673
[TBL] [Abstract][Full Text] [Related]
9. Risk of malignancy index validity assessment in premenopausal and postmenopausal women with adnexal tumors.
Terzic M; Dotlic J; Likic I; Brndusic N; Pilic I; Ladjevic N; Maricic S; Arsenovic N; Maricic Z
Taiwan J Obstet Gynecol; 2013 Jun; 52(2):253-7. PubMed ID: 23915860
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the diagnostic accuracy of International Ovarian Tumor Analysis simple rules and the risk of malignancy index to discriminate between benign and malignant adnexal masses.
Auekitrungrueng R; Tinnangwattana D; Tantipalakorn C; Charoenratana C; Lerthiranwong T; Wanapirak C; Tongsong T
Int J Gynaecol Obstet; 2019 Sep; 146(3):364-369. PubMed ID: 31206642
[TBL] [Abstract][Full Text] [Related]
11. Lesion size affects diagnostic performance of IOTA logistic regression models, IOTA simple rules and risk of malignancy index in discriminating between benign and malignant adnexal masses.
Di Legge A; Testa AC; Ameye L; Van Calster B; Lissoni AA; Leone FP; Savelli L; Franchi D; Czekierdowski A; Trio D; Van Holsbeke C; Ferrazzi E; Scambia G; Timmerman D; Valentin L
Ultrasound Obstet Gynecol; 2012 Sep; 40(3):345-54. PubMed ID: 22611001
[TBL] [Abstract][Full Text] [Related]
12. Ovarian fibroma/fibrothecoma: retrospective cohort study shows limited value of risk of malignancy index score.
Numanoglu C; Kuru O; Sakinci M; Akbayır O; Ulker V
Aust N Z J Obstet Gynaecol; 2013 Jun; 53(3):287-92. PubMed ID: 23611791
[TBL] [Abstract][Full Text] [Related]
13. Role of a risk of malignancy index in clinical approaches to adnexal masses.
Simsek HS; Tokmak A; Ozgu E; Doganay M; Danisman N; Erkaya S; Gungor T
Asian Pac J Cancer Prev; 2014; 15(18):7793-7. PubMed ID: 25292065
[TBL] [Abstract][Full Text] [Related]
14. Are serum HE4 or ROMA scores useful to experienced examiners for improving characterization of adnexal masses after transvaginal ultrasonography?
Kaijser J; Van Gorp T; Smet ME; Van Holsbeke C; Sayasneh A; Epstein E; Bourne T; Vergote I; Van Calster B; Timmerman D
Ultrasound Obstet Gynecol; 2014 Jan; 43(1):89-97. PubMed ID: 23828371
[TBL] [Abstract][Full Text] [Related]
15. Estimating risk of malignancy in adnexal masses: external validation of the ADNEX model and comparison with other frequently used ultrasound methods.
Meys EMJ; Jeelof LS; Achten NMJ; Slangen BFM; Lambrechts S; Kruitwagen RFPM; Van Gorp T
Ultrasound Obstet Gynecol; 2017 Jun; 49(6):784-792. PubMed ID: 27514486
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the importance of the serum levels of CA-125, CA15-3, CA-19-9, carcinoembryonic antigen and alpha fetoprotein for distinguishing benign and malignant adnexal masses and contribution of different test combinations to diagnostic accuracy.
Bozkurt M; Yumru AE; Aral I
Eur J Gynaecol Oncol; 2013; 34(6):540-4. PubMed ID: 24601047
[TBL] [Abstract][Full Text] [Related]
17. A proposal for a new scoring system to evaluate pelvic masses: Pelvic Masses Score (PMS).
Rossi A; Braghin C; Soldano F; Isola M; Capodicasa V; Londero AP; Forzano L; Marchesoni D
Eur J Obstet Gynecol Reprod Biol; 2011 Jul; 157(1):84-8. PubMed ID: 21440361
[TBL] [Abstract][Full Text] [Related]
18. Adding a single CA 125 measurement to ultrasound imaging performed by an experienced examiner does not improve preoperative discrimination between benign and malignant adnexal masses.
Valentin L; Jurkovic D; Van Calster B; Testa A; Van Holsbeke C; Bourne T; Vergote I; Van Huffel S; Timmerman D
Ultrasound Obstet Gynecol; 2009 Sep; 34(3):345-54. PubMed ID: 19585547
[TBL] [Abstract][Full Text] [Related]
19. Accuracy of IOTA Simple Rules, IOTA ADNEX Model, RMI, and Subjective Assessment for Preoperative Adnexal Mass Evaluation: The Experience of a Tertiary Care Referral Hospital.
Vilendecic Z; Radojevic M; Stefanovic K; Dotlic J; Likic Ladjevic I; Dugalic S; Stefanovic A
Gynecol Obstet Invest; 2023; 88(2):116-122. PubMed ID: 36716716
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic accuracy and cost-effectiveness of different strategies to triage women with adnexal masses: a prospective study.
Piovano E; Cavallero C; Fuso L; Viora E; Ferrero A; Gregori G; Grillo C; Macchi C; Mengozzi G; Mitidieri M; Pagano E; Zola P
Ultrasound Obstet Gynecol; 2017 Sep; 50(3):395-403. PubMed ID: 27706929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
